Systematic biopsy should not be omitted in the era of combined magnetic resonance imaging/ultrasound fusion-guided biopsies of the prostate

[1] Ferlay J(2010)Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer Oxf Engl 46 765-781

[2] Parkin DM(2014)Optimization of prostate biopsy Urol Clin North Am 41 299-313

[3] Steliarova-Foucher E(2009)Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens Urology 74 1094-1099

[4] Bjurlin MA(2016)Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR J Urol 196 1613-1618

[5] Wysock JS(2017)EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent Eur Urol 71 618-629

[6] Taneja SS(2016)Magnetic resonance imaging-ultrasound fusion-guided prostate biopsy: review of technology, techniques, and outcomes Curr Urol Rep 17 32-40

[7] Puech P(2016)PI-RADS prostate imaging—reporting and data system: 2015, version 2 Eur Urol 69 16-109

[8] Potiron E(2015)The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system Am J Surg Pathol 313 390-720

[9] Lemaitre L(2015)Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer JAMA 20 100-928

[10] Rosenkrantz AB(2019)Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study Lancet Oncol 68 713-578

[1] Ferlay J(2010)Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer Oxf Engl 46 765-781

[2] Parkin DM(2014)Optimization of prostate biopsy Urol Clin North Am 41 299-313

[3] Steliarova-Foucher E(2009)Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens Urology 74 1094-1099

[4] Bjurlin MA(2016)Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR J Urol 196 1613-1618

[5] Wysock JS(2017)EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent Eur Urol 71 618-629

[6] Taneja SS(2016)Magnetic resonance imaging-ultrasound fusion-guided prostate biopsy: review of technology, techniques, and outcomes Curr Urol Rep 17 32-40

[7] Puech P(2016)PI-RADS prostate imaging—reporting and data system: 2015, version 2 Eur Urol 69 16-109

[8] Potiron E(2015)The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system Am J Surg Pathol 313 390-720

[9] Lemaitre L(2015)Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer JAMA 20 100-928

[10] Rosenkrantz AB(2019)Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study Lancet Oncol 68 713-578